These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31369157)

  • 1. Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs.
    Wang J; Schneider BK; Sun P; Gong X; Qiu J; Li J; Seo YJ; Mochel JP; Cao X
    J Vet Pharmacol Ther; 2019 Sep; 42(5):530-540. PubMed ID: 31369157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Linear Mixed-Effects Pharmacokinetic Modeling of the Novel COX-2 Selective Inhibitor Vitacoxib in Cats.
    Wang J; Schneider BK; Xiao H; Qiu J; Gong X; Seo YJ; Li J; Mochel JP; Cao X
    Front Vet Sci; 2020; 7():554033. PubMed ID: 33102567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the novel COX-2 selective inhibitor vitacoxib in cats: The effects of feeding and dose.
    Wang J; Gong X; Xue J; Zhang S; Li J; Cao X
    J Vet Pharmacol Ther; 2019 May; 42(3):294-299. PubMed ID: 30737806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of vitacoxib, a novel COX-2 inhibitor, in equine plasma using UPLC-MS/MS detection: Development and validation of new methodology.
    Wang J; Zhao T; Kong J; Peng H; Lv P; Li J; Cao X; Zhang S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():270-274. PubMed ID: 28759842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pharmacokinetic properties of vitacoxib in fasted and fed horses.
    Wang J; Xue J; Kong J; Li J; Zhang S; Cao X
    J Vet Pharmacol Ther; 2018 Dec; 41(6):843-847. PubMed ID: 30076623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of vitacoxib in rabbits after intravenous and oral administration.
    Wang J; Xue J; Zhang L; Zhang S; Li J; Cao X
    J Vet Pharmacol Ther; 2019 May; 42(3):368-371. PubMed ID: 30761557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs.
    Wang J; Schneider BK; Xue J; Sun P; Qiu J; Mochel JP; Cao X
    Front Vet Sci; 2019; 6():363. PubMed ID: 31681816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of three formulations of vitacoxib in horses.
    Wang J; Qiu J; Xiao H; Gong X; Sun P; Li J; Zhang S; Cao X
    J Vet Pharmacol Ther; 2020 Jul; 43(4):364-368. PubMed ID: 32162352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety assessment of vitacoxib: 180-day chronic oral toxicity studies.
    Wang J; Zhao T; Tang S; Zhang S; Lv P; Li J; Cao X
    Regul Toxicol Pharmacol; 2018 Jun; 95():244-249. PubMed ID: 29601910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic profiles of the novel COX-2 selective inhibitor cimicoxib in dogs.
    Kim TW; Lebkowska-Wieruszewska B; Owen H; Yun HI; Kowalski CJ; Giorgi M
    Vet J; 2014 Apr; 200(1):77-81. PubMed ID: 24461644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog.
    Jeunesse EC; Schneider M; Woehrle F; Faucher M; Lefebvre HP; Toutain PL
    BMC Vet Res; 2013 Dec; 9():250. PubMed ID: 24330630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
    Olsson-Gisleskog P; Jacqmin P; Perez-Ruixo JJ
    Clin Pharmacokinet; 2007; 46(2):159-73. PubMed ID: 17253886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic modeling and simulation of etodolac following single oral administration in dogs.
    Baek IH
    Xenobiotica; 2019 Aug; 49(8):981-986. PubMed ID: 30216103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses.
    Kvaternick V; Pollmeier M; Fischer J; Hanson PD
    J Vet Pharmacol Ther; 2007 Jun; 30(3):208-17. PubMed ID: 17472652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of Large Pharmacokinetic Data Using Nonlinear Mixed-Effects: A Paradigm Shift in Veterinary Pharmacology. A Case Study With Robenacoxib in Cats.
    Pelligand L; Soubret A; King JN; Elliott J; Mochel JP
    CPT Pharmacometrics Syst Pharmacol; 2016 Nov; 5(11):625-635. PubMed ID: 27770596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.
    Gastine S; Lehrnbecher T; Müller C; Farowski F; Bader P; Ullmann-Moskovits J; Cornely OA; Groll AH; Hempel G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers.
    Dyck JB; Maze M; Haack C; Azarnoff DL; Vuorilehto L; Shafer SL
    Anesthesiology; 1993 May; 78(5):821-8. PubMed ID: 8098191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of olmesartan following oral administration of its prodrug, olmesartan medoxomil: in healthy volunteers and hypertensive patients.
    Yoshihara K; Gao Y; Shiga H; Wada DR; Hisaoka M
    Clin Pharmacokinet; 2005; 44(12):1329-42. PubMed ID: 16372830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.